Autopsy report · NCT07031882

Liberty Analyzer WBC System: Reference Interval Study

“For interim analysis.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 10 months before it started.
• Suspended: paused, and may or may not restart.
• 300 participants planned (an estimate, not an actual count).

Vital statistics

Status

Suspended

Sponsor

Entia Ltd

Sponsor type

Industry

Conditions

Healthy Volunteers

Interventions

Liberty Analyzer WBC System

Participants

300 (planned, not actual)

Sites

1

Countries

United States

Trials that died the same way

• Epcoritamab and Tazemetostat for the Treatment of Relapsed or Refractory Grade I-IIIa Follicular Lymphoma
  “Pending Interim Analysis” (76% match in meaning)
• The Role of Post-traumatic Inhibition of the Innate and Adaptive Immune System in the Development of Infectious Complications in Severely Injured Patients
  “Interim analysis provided enough data” (76% match in meaning)
• Verapamil vs Steroid to Prevent Keloid Recurrence
  “Objective of study achieved after interim analysis.” (71% match in meaning)
• Efficacy Study of Polyunsaturated Fatty Acids in Children and Adolescents With Attention Deficit/ Hyperactivity Disorder
  “The sample size of the planned interims analysis was achieved” (70% match in meaning)
• ICVT in HPV-induced Genital Lesions of Immunocompromised and Immunocompetent Patients
  “Lack of effect in interim analysis” (69% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.